Medtronic plc (MDT)

Market Cap	124.18B +6.5%
Revenue (ttm)	35.48B +6.9%
Net Income	4.61B +8.3%
EPS	3.58 +9.1%
Shares Out	1.28B
PE Ratio	27.06
Forward PE	16.26
Dividend	$2.84 (2.93%)
Ex-Dividend Date	Dec 26, 2025

Volume	7,188,299
Open	97.18
Previous Close	97.58
Day's Range	96.47 - 97.87
52-Week Range	79.55 - 106.33
Beta	0.72
Analysts	Buy
Price Target	109.82 (+13.38%)
Earnings Date	Feb 17, 2026

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: NYSE
• Ticker Symbol: MDT
• Website: https://www.medtronic.com

Financial Performance

In fiscal year 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Analyst Summary

According to 19 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $109.82, which is an increase of 13.38% from the latest price.

Price Target

$109.82

(13.38% upside)

Analyst Consensus: Buy